ADDF-Harrington Scholar Program - Request for Proposals

The ADDF-Harrington Scholar Program is designed to accelerate the translation of innovative research that could treat, prevent, slow, or cure people with Alzheimer’s disease.

Please note that this is a special funding opportunity separate from ADDF’s Core Funding Programs.

The ADDF-Harrington Scholar Program is a collaboration between the Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute. The goal of developing new therapies will be achieved by providing award recipients with both research funding and committed project support by a team of pharmaceutical industry experts within the Harrington Discovery Institute Innovation Support Center. The Innovation Support Center’s Advisory Panel is staffed by drug development experts who have held senior management positions in established pharmaceutical companies. They have significant experience in commercial drug development, have broad, established networks, and collectively span a wide range of knowledge in drug discovery and development.

Funding Priorities
Novel targets are highly encouraged. Current target areas of interest include, but are not limited to:

• Neuroprotection
• Inflammation
• Vascular function
• Mitochondria & metabolic function
• Proteostasis
• ApoE
• Epigenetics
• Synaptic activity & neurotransmitters

The ADDF-Harrington Scholar Program does not support anti-amyloid (e.g. anti-amyloid aggregation, Aβ vaccines, β- or ɣ-secretase inhibitors) or cholinesterase inhibitor approaches.

Award Information Funding Amount: Up to $300,000 per year for 2 years

Deadlines Letter of Intent: May 25, 2018, 11:59 PM EDT
Full Proposal: August 10, 2018, 11:59 PM EDT

Αναλυτικές πληροφορίες - Αιτήσεις: researchgate.net